RMSL Stock Overview
Focuses on the development and distribution of products to help people affected by sleep apnea worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
REMSleep Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0079 |
| 52 Week High | US$0.026 |
| 52 Week Low | US$0.0027 |
| Beta | 0.80 |
| 11 Month Change | -8.14% |
| 3 Month Change | -15.05% |
| 1 Year Change | -53.80% |
| 33 Year Change | -40.60% |
| 5 Year Change | -9.20% |
| Change since IPO | -99.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| RMSL | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 21.5% | -0.4% | -1.0% |
| 1Y | -53.8% | 20.3% | 30.3% |
Return vs Industry: RMSL underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: RMSL underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| RMSL volatility | |
|---|---|
| RMSL Average Weekly Movement | 9.9% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RMSL's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: RMSL's weekly volatility has decreased from 15% to 10% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 2 | Tom Wood | remsleep.com |
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves sleep product distributors, home care dealers, private sleep labs, product end users, sleep physicians, medical group, and hospitals, as well as medical associations.
REMSleep Holdings, Inc. Fundamentals Summary
| RMSL fundamental statistics | |
|---|---|
| Market cap | US$11.43m |
| Earnings (TTM) | -US$1.81m |
| Revenue (TTM) | US$130.19k |
92.5x
P/S Ratio-6.6x
P/E RatioIs RMSL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RMSL income statement (TTM) | |
|---|---|
| Revenue | US$130.19k |
| Cost of Revenue | US$864.97k |
| Gross Profit | -US$734.78k |
| Other Expenses | US$1.08m |
| Earnings | -US$1.81m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0012 |
| Gross Margin | -564.38% |
| Net Profit Margin | -1,393.37% |
| Debt/Equity Ratio | 0% |
How did RMSL perform over the long term?
See historical performance and comparison